Unanswered Questions
The biggest open questions about adaptogens: whether the category is valid, how they work, which extracts count, long-term safety, special groups and conservation.
Content last updated . This page has not been medically reviewed.
Safety first. Natural products can cause side effects and interact with medicines. Read who should be careful, by situation before you use anything on this page.
Short answer. Several basic questions about adaptogens are still open: whether "adaptogen" is a useful category, how any of these plants work, how results carry from one extract to another, and how safe long-term use is. For pregnancy, children and medicine combinations, the sources we read say little. Until more is known, use these plants only after talking with a pharmacist or clinician if you take medicines, are pregnant or breastfeeding, or have liver, thyroid or autoimmune conditions.
How the sources define the terms
"Adaptogen" was proposed by N. V. Lazarev, a scientist from the USSR; the EU herbal committee dates the term to 1947 and a 2018 review to 1940. [1][2] Definitions differ. One review describes adaptogens as having three criteria (non-specific action, helping maintain homeostasis, and not harming normal functions) and sorts them into primary and secondary groups. [2] The EU herbal committee (2008) says the principle of adaptogenic action needs further clarification and that the term is not accepted in the commonly used pharmacological and clinical vocabulary of the EU. [1]The open questions
| Question | What the sources say | Status |
|---|---|---|
| Is "adaptogen" a valid category? | The EU committee says the principle needs further clarification and studies in pre-clinical and clinical areas. [1] Which plants count differs by author; NCCIH calls astragalus an adaptogen but says there is not sufficient reliable evidence to know whether it is useful for any health condition. [3] | Unresolved |
| How do they work? | A 2010 review links stress-protective activity in animals and cells to the HPA axis and other pathways. [4] The EU committee says molecular targets are still unknown. [1] | Preclinical; mechanism not established |
| Do results transfer between extracts? | NCCIH notes ashwagandha studies used a variety of preparations. [5] A 2026 review lists heterogeneity in herbal preparations among trial limits. [6] | Not shown |
| Are they safe long-term? | NCCIH says there is not enough information to reach conclusions about the long-term safety of ashwagandha. [5] For Asian ginseng it says most trials were shorter than 3 months and that questions have been raised about long-term safety. [7] | Insufficient evidence |
| Pregnancy, breastfeeding, children | NCCIH advises avoiding ashwagandha in pregnancy and not using it while breastfeeding. [5] It says little is known about rhodiola in pregnancy or breastfeeding. [8] Proper evidence not found for randomized trials: a PubMed search on 2026-10-23 (adaptogen in the title or abstract, with pregnancy, and separately with child or adolescent, and randomized controlled trial) returned no records. | Insufficient evidence |
| Which adaptogen is better? | Proper evidence not found. The same search style (adaptogen with head-to-head or active comparator) returned no records; two ashwagandha-and-rhodiola records matched a wider search, and their titles describe placebo-controlled trials of formulas. | Insufficient evidence |
| Are interactions with medicines well mapped? | The EU monograph on rhodiola says no clinically relevant interactions have been observed. [9] NCCIH reports interactions between rhodiola and losartan, a blood pressure medicine. [8] | Mixed |
Searches like these use only the words in titles and abstracts, so they can miss studies that do not use the word "adaptogen". They show what we found, not that nothing exists.
Questions about the plants themselves
- Supply. A 2013 review says harvesting for the Asian traditional medicine market made American ginseng North America's most harvested wild plant for two centuries, eventually prompting a CITES Appendix II listing. [10] A 2021 review found wild rhodiola populations in main harvesting areas continue to decrease while demand rises, along with adulteration and substitution. [11] Whether products fully reflect the plant on the label is a quality question; see adaptogen regulation and conservation and contamination, substitution and adulteration.
- Traditional use. How closely modern capsules match the way a tradition prepared a plant is not settled by trials; see traditional use vs clinical evidence.
What a reader can safely do
- Bring the product label and every medicine and supplement you use to a pharmacist or clinician. See talking with a health professional.
- Treat claims of "balancing hormones" or "fixing adrenals" with caution; see adrenal fatigue and adrenal support claims.
- For current evidence on specific uses, see how much human research exists.
Frequently asked questions
Are adaptogens proven?
Reviews describe promising results for some uses and clear limits. For example, a 2022 meta-analysis found lower anxiety and stress with ashwagandha but rated certainty low. [12]
Is it known how adaptogens work?
Not in a settled way. The EU herbal committee says the molecular targets are still unknown, and preclinical work points to several pathways. [1][4]
Are adaptogens safe to take for years?
Proper evidence not found for long-term safety in the sources we read. NCCIH says not enough information exists for ashwagandha. [5]
Are adaptogens safe in pregnancy?
NCCIH says ashwagandha should be avoided during pregnancy, and little is known about rhodiola. [5][8] Ask an obstetric clinician before any herbal product.
Which question matters most for me?
That depends on your health and medicines. A pharmacist or clinician can help with interactions, which NCCIH lists for ashwagandha with diabetes, blood pressure, immune-suppressing, sedative, anti-seizure and thyroid medicines. [5]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Limits and uncertainty
References
- European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Reflection paper on the adaptogenic concept. EMEA/HMPC/102655/2007, adopted 8 May 2008. Read 2026-10-23.
- Liao LY, He YF, Li L, et al. A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide. Chin Med. 2018. PubMed 30479654, full text at PMC6240259. Read 2026-10-23.
- National Center for Complementary and Integrative Health (NIH). Astragalus: Usefulness and Safety. Page read 2026-10-23. Read 2026-10-23.
- Panossian A, Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals (Basel). 2010. PubMed 27713248. Read 2026-10-23.
- National Center for Complementary and Integrative Health (NIH). Ashwagandha: Usefulness and Safety. Last updated March 2023. Read 2026-10-23.
- Rao YC, Kumari KM, Kateel R, Mohanbabu Vittalrao A. Phyto adaptogens in stress management and health optimization: current understanding and future perspectives. Complement Med Res. 2026. PubMed 42721096. Read 2026-10-23.
- National Center for Complementary and Integrative Health (NIH). Asian Ginseng: Usefulness and Safety. Page read 2026-10-23. Read 2026-10-23.
- National Center for Complementary and Integrative Health (NIH). Rhodiola: Usefulness and Safety. Page read 2026-10-23. Read 2026-10-23.
- European Medicines Agency, HMPC. European Union herbal monograph on Rhodiola rosea L., rhizoma et radix. EMA/HMPC/24177/2023, Final, Revision 1, 20 March 2024. Read 2026-10-23.
- McGraw JB, Lubbers AE, Van der Voort M, et al. Ecology and conservation of ginseng (Panax quinquefolius) in a changing world. Ann N Y Acad Sci. 2013. PubMed 23398402. Read 2026-10-23.
- Brinckmann JA, Cunningham AB, Harter DEV. Running out of time to smell the roseroots: reviewing threats and trade in wild Rhodiola rosea L. J Ethnopharmacol. 2021. PubMed 33358852. Read 2026-10-23.
- Akhgarjand C, Asoudeh F, Bagheri A, et al. Does ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022. PubMed 36017529. Read 2026-10-23.